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Abstract
Febrile seizures (FSs) typically occur at the onset of fever and do not recur within the same febrile
episode despite enduring or increased hyperthermia. Recurrent seizures during the same febrile
episode are considered “complex,” with potentially altered prognosis. A characterized immature rat
model of FS was used to test the hypotheses that (1) a first FS influences the threshold temperature
for subsequent ones, and (2) the underlying mechanisms involve the release and actions of the
endogenous inhibitory hippocampal neuropeptide Y (NPY). Experimental FSs were induced two or
three times, at 3- to 4-h intervals, and threshold temperatures measured. To determine the potential
effects of seizure-induced endogenous NPY on thresholds for subsequent seizures, an antagonist of
the major hippocampal NPY receptor (type 2) was infused prior to induction of the second seizure.
As an indicator of NPY release, NPY expression was determined 4 and 24 h later. Threshold core
and brain temperatures for hyperthermic seizures were consistent with those observed during human
fever. Threshold temperatures for a second and third seizure were significantly and progressively
higher than those required for the first. This “protective” effect involved induction of endogenous
NPY because it was abolished by the NPY antagonist. In addition, NPY mRNA expression was
increased in dentate gyrus, CA3 and CA1, after an experimental FS, consistent with peptide release.
Collectively these data indicate that the absence of repetitive seizures during a febrile episode
involves the inhibitory actions of endogenous NPY, suggesting that the signaling cascade triggered
by this peptide might provide targets for therapeutic intervention.
Index Entries
Seizures; fever; febrile; neuropeptide; NPY; hippocampus; animal model; rat; immature
Introduction
Febrile seizures (FSs) constitute the most prevalent seizure type in infants and young children,
involving 2–5% of children under age 5 (Nelson and Ellenberg, 1981; Verity and Golding,
1991; Stafstrom, 2002). Remarkably, the processes occurring during and immediately after
these seizures are poorly understood. For example, the identity of neuronal circuits that are
activated, and whether a single FS predisposes to—or protects from—the occurrence of further
seizures, have remained unresolved. Obvious limitations on the study of the mechanisms,
pathophysiology, and cellular consequences of FSs derive from the inability to predict their
timing or induce them in the human (Toth et al., 1998; Dubé et al., 2000; Baram, 2002).
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Observational studies of FSs have led to their classification into simple and complex
(International League Against Epilepsy, 1981). Simple FSs carry a benign prognosis (Nelson
and Ellenberg, 1981; Annegers et al., 1987; Verity and Golding 1991; Offringa et al., 1994;
Berg and Shinnar, 1996a; Stafstrom, 2002), and analyses of their typical features have
contributed to enhanced precision of epidemiological prospective studies addressing their
outcome (Annegers et al., 1987; Berg and Shinnar, 1996a). The key clinical features of simple
FSs include the occurrence of a single ictal event during a febrile illness (American Academy
of Pediatrics, 1999). Not uncommonly, the seizure may be the first indication of the presence
of fever (Offringa et al., 1994; American Academy of Pediatrics, 1999), and several studies
have documented the relative scarcity of repetitive seizures within a single febrile episode
(Annegers et al., 1987; Offringa et al., 1994; Berg and Shinnar, 1996b). Thus, although core
temperatures that suffice to induce a FS might persist for several hours or might even be
exceeded, repeated seizures occur uncommonly for example, in 13.7% of cases (Berg and
Shinnar, 1996a). The occurrence of repeated seizures during a single febrile episode is unusual
enough to be considered a “complex” feature by the Commission of the International League
Against Epilepsy (International League Against Epilepsy, 1981; American Academy of
Pediatrics, 1999) and is associated with a higher risk of subsequent unprovoked seizures, that
is, epilepsy (Annegers et al., 1987; Berg and Shinnar, 1996a).
The paucity of further seizures, despite enduring high core temperatures, might result from
dissociation between the measured core temperature and the actual brain temperature. This
type of divergence has been demonstrated during neuropathological states, including ischemia
and trauma, in both humans (Schwab et al., 1997; Henker et al., 1998) and animal models
(Colbourne et al., 1993). If, during fever (or hyperthermia), core temperature rises
disproportionately to that of brain, then threshold brain temperatures for the induction of
seizures may not be reached. Alternatively, the first FS in itself might modulate neuronal
excitability in the involved circuits, increasing the threshold temperature required for triggering
additional seizures. Strong candidates for mediating such hours-long protection are
endogenous inhibitory neuropeptides that might be released during the seizures, because these
neuromodulators tend to exert actions within this time frame (Hokfelt et al., 2000). Among
characterized peptides, evidence is mounting for the involvement of neuropeptide Y (NPY) in
modulation of neuronal excitability under both physiological and pathological conditions,
including those occurring during seizures (Klapstein and Colmers, 1993; Gruber et al., 1994;
Vezzani et al., 1996; Woldbye et al., 1997). NPY, expressed in specific neuronal populations
in hippocampus (Kohler et al., 1986; Gruber et al., 1994), has been found to reduce limbic
network excitability both in vivo and in vitro (Klapstein and Colmers, 1993; Woldbye et al.,
1997; Richichi et al., 2004).
Although the mechanisms preventing recurrent FSs are obviously important for the clinical
management of infants and children with fever and FSs (Annegers et al., 1987; Offringa et al.,
1994; American Academy of Pediatrics, 1999), they are difficult (if not impossible) to study
in the human. Therefore, the goals of the current study were to utilize a characterized animal
model in the immature rat (Toth et al., 1998; Dubé et al., 2000) for testing the hypothesis that
a single hyperthermic seizure reduces the likelihood for a second seizure via activation of
neuropeptide-mediated inhibition.
Materials and Methods
Experimental FS Paradigm
Sprague-Dawley-derived rats, born and maintained in quiet facilities under controlled
temperatures (21–22°C), a 12-h light schedule, and unlimited access to food and water, were
used for these experiments. All experimental procedures were approved by the Institutional
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Animal Care Committee and conformed to the National Institutes of Health (NIH) guidelines
for the care of experimental animals.
Experimental FSs were provoked as described previously (Toth et al., 1998; Dubé et al.,
2000). Briefly, hyperthermia (i.e., increased body and brain temperatures) was induced in 10-
to 11-d-old rats, using a warmed airstream directed ∼30 cm above them. Core temperatures
were measured before hyperthermia induction and at the onset of hyperthermia-provoked
seizures. The correlation of behavioral and electrographic seizures that involve the
hippocampal circuit has been documented (Dubé et al., 2000; Bender et al., 2003) and is shown
in Fig. 1A. In general, there is excellent correlation between EEG and behavioral seizure
duration. For evaluation of threshold temperatures, brain and/or rectal temperatures required
for the induction of experimental FS were noted at the onset of seizures and hyperthermia was
then terminated. For determination of NPY induction, hyperthermia was maintained for 30
min, resulting in seizure duration of approx 20 min (Dubé et al., 2000). For determination of
threshold temperatures, seizures were stopped immediately after onset by discontinuing the
hyperthermia. Animals were then placed on a cool surface and returned to their home cages.
For determination of the effects of a single experimental FS on threshold temperatures of
subsequent ones, seizures were induced two or three times, at 3- to 4-h intervals, to approximate
the clinical situation of a febrile illness (Berg and Shinnar, 1996b).
Brain and Core Temperature Measurements
To verify the correlation of brain and core (rectal) temperatures associated with onset of
seizures, brain temperatures were measured directly and validated using two separate methods.
First, a group of immature rats (n = 8) were implanted with a stainless steel cannula positioned
immediately above the dura (Baram et al., 1992), 24 h prior to the experiment. On the day of
the experiment, baseline and threshold temperatures were obtained via the cannula, using a
probe marked precisely to reach the dura. Each baseline measure was repeated in quintuplicate;
threshold readings, by definition, were obtained once only. A second means for measuring
brain temperature involved anesthetizing the skin of immature rats and directing the probe
through the cranial suture to the dura (n = 8). Because the results were essentially identical to
those obtained using the chronic cannula (35.62 ± 0.15°C vs. 35.54 ± 0.19°C, respectively),
the latter method, associated with minimal discomfort, was chosen. It should be noted that
permanent implants of temperature sensors are not feasible in the neonatal rat in the absence
of sufficient subcutaneous tissue, as sensor implantation results in skin sloughing.
In Vivo Electrophysiology
To ascertain the concordance of the behavioral and electrophysiological seizures provoked by
hyperthermia, a separate group of 9-d-old rats were implanted unilaterally in the dorsal
hippocampus with bipolar twisted wire electrodes, as described previously (Baram et al.,
1992; Dubé et al., 2000). On the following day, baseline hippocampal EEGs, as well as
recordings during hyperthermia-induced seizures, were obtained in freely moving rats via long
flexible wires, as described elsewhere (Baram et al., 1992; Dubé et al., 2000). Correct electrode
placement was verified in all animals.
Determination of the Effects of NPY Y2 Receptor Antagonist on Subsequent Seizure
Threshold Temperatures
To investigate the potential mechanisms underlying the increased resistance of limbic circuits
to subsequent FSs, an NPY receptor type 2 (Y2R) antagonist was used (Malmstrom, 2001;
Vezzani and Sperk, 2004). Specifically, BIIE0246 (courtesy of Dr. A. Vezzani) was dissolved
in 25% polyethylene glycol 300 and administered at a dose of 100 nm/kg; 2.5 nm/μL, into the
cerebral ventricle, 10 min before a second experimental FS was induced (4 h after the first).
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To eliminate potential con-founders resulting from the infusion procedure, sham infusions were
carried out also before the first seizure.
In Situ Hybridization Histochemistry and Analysis for NPY mRNA
In situ hybridization histochemistry (ISH) was performed on brain sections from animals
sacrificed 4 or 24 h after experimental FS induction (n = 6 per group), as described previously
(Brunson et al., 2001). Briefly, 20-μm coronal sections were mounted on gelatin-coated slides
and stored at −80°C. Sections were thawed, air-dried, fixed in paraformaldehyde, dehydrated
and rehydrated through graded ethanols, and exposed to 0.25% acetic anhydride in 0.1 M
triethanolamine and dehydrated. Prehy-bridization (for 1 h) and hybridization (overnight) were
performed at 40°C in a humidified chamber. The NPY deoxyoligonucleotide probe (Genosys)
complementary to the coding region of NPY mRNA, was 3′-end-labeled with 35S-dATP.
Sections were washed as described (Brunson et al., 2001) and apposed to film (Hyperfilm β-
Max; Amersham, Airlington Heights, IL) for 7 d.
For analysis of data, six anatomically matched sections, containing the dorsal hippocampus
(anterior [A] 2.3–2.6 mm in reference to the interaural line [Sherwood and Timiras, 1970]),
per animal, were used. Optical density of hybridization signal was measured over the regions
of interest, without knowledge of treatment and by subtracting the density of corpus callosum
for background, and compared with 14C calibration standards, as described in detail in Eghbal-
Ahmadi et al. (1999) and Brunson et al. (2001).
Data Analysis
Data are presented as mean ± S.E. The significance (p < 0.05) of observed differences among
experimental and control groups was evaluated using ANOVA or Student's t-test with Welch's
correction, as appropriate.
Results
Experimental FSs Involve the Hippocampus and Are Elicited at Physiological Temperatures
As described previously, hyperthermia-induced seizures were characterized by an arrest of
heat-induced hyperactivity, body flexion, and biting of an extremity, occasionally followed by
clonus (Dubé et al., 2000; Bender et al., 2003). The hippocampal electrographic (EEG)
correlates of these seizures are shown in Fig. 1A. As apparent in the figure, the low-amplitude
multiple-frequency background activity (top trace) was converted by the hyperthermia into
rhythmic high-voltage-spike and spike-wave trains. Seizure threshold temperature (measured
rectally) in this group of animals was 40.88 ± 0.3°C.
Brain and Core Temperatures in Immature Rats Are Correlated Both at Seizure Threshold
and During Normothermic Conditions, but the Correlation Is Temperature Dependent
Repeated measurements of core and brain temperatures for each individual rat were tightly
clustered and reproducible. Core values measured at 5-min intervals over a 25-min period in
animals maintained on a euthermic pad were within 0.1°C for a given 10- to 11-d-old rat and
averaged 32.88 ± 0.07°C (n = 10), as is shown in Fig. 1B. These temperatures were virtually
identical to those obtained in rats upon removal from home cages (data not shown). Under the
same conditions, brain temperatures for an individual rat were also highly consistent (Fig.1C).
Interestingly, mean euthermic brain temperatures were 2.8°C higher than mean core values:
The divergence of brain and core temperature was consistent among individual animals. In
addition, this divergence was temperature dependent and approached zero at temperature
ranges provoking seizures. Thus, at the onset of hyperthermic seizures (i.e., at threshold
temperatures), brain temperatures averaged 40.7 ± 0.2°C (n = 29) compared with core
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temperatures of 40.88 ± 0.3°C (n = 31). These data indicate that within the confines of the
model and methods used here, core measurements provide an adequate approximation of brain
threshold temperatures for experimental FSs.
A Single Hyperthermia-Induced Seizure Increases Threshold Temperature to a Subsequent
One
To determine whether sustaining a single hyperthermic seizure influences the probability of
having a second, core temperatures required to generate a FS were evaluated for rats subjected
to hyperthermia once, twice, or three times at 3- to 4-h intervals. As shown in Fig. 2, baseline
core temperatures of immature rats did not differ prior to each hyperthermia session (repeated
measure ANOVA, p=0.991). However, threshold temperatures were significantly higher for
the second seizure, compared with the first, and were elevated even further for the third seizure
(repeated measure ANOVA, p = 0.0015; F = 7.53, degrees of freedom = 2). These data indicate
that an experimental FS “protects” from developing another in response to subsequent
hyperthermia by raising the temperature required to provoke a seizure.
Threshold Elevation for a Second Experimental FS Is Abolished by NPY Y2R
As shown in Fig. 3, administration of the selective antagonist of NPY Y2R abolished the
increased threshold temperature for a second seizure compared with the first. (Threshold for
the second seizure after NPY Y2R antagonist was 40.8 ± 0.2°C compared with 41.6 ± 0.2°C
in animals treated with vehicle; p < 0.05; Fig. 3B). These findings are consistent with the
involvement of endogenous NPY in the mechanisms underlying the increased resistance of
limbic circuits to a second experimental FS.
Experimental FSs Result in an Enhanced NPY Expression
For endogenous CNS neuropeptides, release typically triggers synthesis (Hokfelt et al.,
2000), so that although direct measurement of peptide release at individual synapses of neonatal
hippocampus may not be feasible (because of subfemtomolar quantities and spatial constraints
[Merali et al., 1998]), increased mRNA expression of a given peptide provides an adequate
measure of its prior secretion. As shown in Fig. 4, ISH analysis of NPY expression within the
hippocampal formation demonstrated increased steady-state NPY mRNA levels over the
granule cell layer of the dentate gyrus (DG) already by 4 h after the seizures, and in DG, CA3
and CA1 areas, by 24 h. This finding is consistent with release-coupled synthesis of NPY, that
is, with seizure-evoked release and actions of this endogenous inhibitory neuropeptide. In
addition, NPY mRNA levels increased at 24 h after a 20-min hyperthermic seizures also in the
medial amygdala nucleus but not in the prefrontal cortex (data not shown).
Discussion
The principal findings of these studies are: (1) In the immature rat model, having “a first FS”
leads to increased threshold for additional ones; (2) this effect lasts for several hours and is
augmented further after a second seizure; and (3) the mechanisms for this “protective” effect
of experimental FSs involve the actions of the endogenous inhibitory peptide NPY. Taken
together, these findings provide a neurobiological basis for the prevalence of a single seizure
per febrile episode in children and suggest that a flurry of FSs might imply significant
breakdown of protective inhibitory mechanisms in the limbic circuit.
A Single Experimental FS Decreases the Probability of Having Another
The current experiments demonstrate that a single hyperthermic seizure leads to a significant
elevation of temperatures required to elicit a second (or third) seizure. This finding recapitulates
the typical situation in the human. In 80–90% of human FSs, only a single seizure occurs within
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a febrile episode. This is true even when the fever is sustained or fluctuates with antipyretics.
In several relatively large epidemiological studies of FSs, the total number of complex seizures
accounted for 20–35% of all FSs (Annegers et al., 1987; Berg and Shinnar, 1996a).Within the
group of complex FSs, repetitive seizures comprised about 50%, occurring in 13.7% (Berg and
Shinnar, 1996a), 14.7% (Berg et al., 1992), 16% (Berg and Shinnar, 1996b), or 19% (Annegers
et al., 1987) of all seizures. These data indicate that the majority of infants and children are
resistant to having more than one seizure during a given febrile episode. The basis for this
clinically observed resistance is difficult to determine, in part because of the inability to
measure true “threshold temperatures” in febrile children: A delay between seizure onset and
evaluation of the child's temperature is almost universal, and this delay is highly variable
(Berg, 2002).
Reproducing the human phenomenon of “one seizure per febrile episode” within the immature
rat model permitted the designing of experiments to determine the mechanisms involved. It
should be noted that the same animal model shares several key features of human FS: age
specificity, a physiologically relevant threshold temperature range that is concordant with high
fever in children (Berg et al., 1992); and minimal morbidity (Dubé et al., 2000; Baram,
2002). This model has suggested that even clinically nonfocal hyperthermia-induced seizures
involve hippocampal formation (Toth et al., 1998; Dubé et al., 2000; Baram, 2002) (and see
Fig. 1A) and has facilitated in vivo and in vitro studies to define the short- and long-term
consequences of FSs, as well as the mechanisms involved.
In the studies reported here, a higher temperature was required to induce seizures following a
single hyperthermic seizure. This effect was progressive with additional seizures, whereas
baseline core temperatures did not differ before each seizure. In addition, no significant
dissociation occurred between core and brain temperatures at onset of the first seizure or a
subsequent one (data not shown), indicating that the resistance to a second seizure was not an
artifact of the fact that core temperature did not reflect brain temperatures at seizure onset.
What, then, might be the mechanism(s) by which a single experimental FS results in elevation
of the temperature required to elicit further seizures?
The Mechanism for Seizure-Induced Increase of Threshold Temperature, Lasting for Hours,
Might Involve Hippocampal Neuropeptides
The rarity of repetitive FSs during a single fever episode might result from an alteration of the
excitability of neuronal circuits involved in their generation. Strong candidates for mediating
protective effects in the time frame of hours are endogenous neuropeptides (see Introduction).
A candidate peptide is corticotropin-releasing hormone (CRH), which is abundant in
developing hippocampus (Chen et al., 2001), excites hippocampal neurons (Aldenhoff et al.,
1983; Hollrigel et al., 1998), and precipitates seizures in immature rodents (Baram et al.,
1992; Baram and Hatalski, 1998). Thus, FS-induced reduction of CRH levels in hippocampal
synapses might be anti-excitatory. However, experimental FSs increase CRH mRNA
expression in hippocampal formation (Hatalski et al., 2000), consistent with enhanced release
of the endogenous peptide, thus excluding involvement of CRH in seizure-induced
“protection” from further hyperthermic seizures.
Here, the reduced seizure susceptibility after an experimental FS was attributable to actions of
the inhibitory hippocampal peptide NPY. Abundant expression of NPY in hippocampal
formation, typically in the interneuron, has been found (Deller et al., 1990). The peptide reduces
excitability within the hippocampal network during seizures (Woldbye et al., 1996), acting
presynaptically via Y2Rs (Schwarzer et al., 1998; El Bahh et al., 2002 but see- Woldbye et al.,
1997) to reduce glutamate release onto hippocampal pyramidal cells. The information for the
presence, location, and pharmacology of NPY and its receptors prompted us to employ a Y2R
blocker in concentrations considered relatively specific, and this antagonist abrogated the
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progressive increase in seizure threshold, suggesting that activation of these receptors by
endogenous NPY contributed to the augmented seizure threshold.
Independent support for release of endogenous hippocampal NPY after experimental FS in the
current studies was provided by increased NPY mRNA levels in hippocampus within hours
after such seizures. This increased peptide production (Fig. 4), reported also in other seizure
models (Vezzani et al., 1996;Schwarzer et al., 1998), is typical of release-coupled synthesis,
described for many CNS peptides (Hokfelt et al., 2000). Taken together, the data indicate a
role for endogenous NPY in the mechanisms by which an experimental FS “protects” the
hippocampus from the occurrence of a second.
Relevance of These Studies to Human FSs
The current study documents that a single FS leads to enhanced inhibitory processes in the
normal hippocampal circuit, which protect it from ensuing fever-provoked seizures within
hours of the original ictus. The studies clarify the underlying mechanisms, providing a
neurobiological basis for the “single-seizure-per-febrile-episode” principle operating in most
children. The studies also imply that if recurrent seizures do occur within a single febrile
episode, they may indicate that the underlying antiexcitatory processes are not “normal” and
encourage a search (e.g., EEG, MRI) for predisposing factors that might have rendered the
individual more susceptible to fever-induced seizures. In addition, recognizing that a FS leads
to “protective” elevations of temperatures required for further seizures might influence
management decisions: the scenario of repetitive seizures within a febrile episode with stable
temperatures should raise the concern that these seizures might be provoked by an insult beyond
the fever itself. A vigorous search for more malignant causes for the fever, (acute infection,
hemorrhage), which may elicit breakdown of normal protective mechanisms, should be
considered.
In summary, in the immature rat model, a single FS leads to enhanced release and actions of
an inhibitory neuropeptide that serves to protect against the occurrence of additional seizures.
These findings carry significant implications for the evaluation and management of repetitive
FSs in infants and children.
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Fig. 1.
(A) Electrophysiological features of hyperthermia-induced seizures in immature rats. EEGs
were recorded using bipolar electrodes from dorsal hippocampus of 10-d-old rats. Top: Typical
hippocampal activity in a euthermic animal, consisting of low-amplitude, nonrhythmic awake
pattern (Dubé et al., 2000; Bender et al., 2003). Bottom: Rhythmic, high-amplitude
epileptiform spike waves indicate a seizure. During this electrographic seizure, the animal was
essentially motionless, with an occasional jerk (arrow) or oral automatisms. Calibration bars:
1 s; 50 μV. (B,C) Validity and correlation of brain and core temperatures in the euthermic
immature rat. (B) Core temperatures of individual rats are tightly clustered within and among
individuals. Symbols denote mean ± S.E. of five measurements obtained over 25 min from
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individual animals kept on a euthermic pad. These were identical to temperatures obtained in
the home cage and represent normothermic values for the 10-d-old rat. (Values for rat no. 1
were too clustered to visualize error bars). (C) Brain temperatures, obtained under the same
conditions, by direct dural measurements (see Materials and Methods). These temperatures
were, on average, 2.8°C higher than core temperatures.
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Fig. 2.
Progressive increase of temperatures required for further seizure provocation after an
experimental FS in the immature rat. (A) Threshold temperatures (measured at seizure onset)
were significantly higher for the second seizure and elevated even further for the third (repeated
measure ANOVA, p = 0.0015). As explained in the text, at this temperature range, brain and
core temperatures converged. (B) Baseline core temperatures, measured immediately prior to
induction of hyperthermia, were not influenced by previous seizures, elicited 3–4 h earlier.
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Fig. 3.
The progressive increase of threshold temperature for a second experimental FS was abolished
by a selective antagonist of NPY Y2Rs. (A) Comparison of threshold for a first (1st) and second
(2nd) seizure in untreated control rats (CTL) and those infused with vehicle (VEH). The asterisk
(*) denotes a significant difference from the first seizure threshold. (B) Comparison of
threshold for a first and second seizure in rats infused with vehicle and those infused with NPY
receptor antagonist prior to the second seizure. The solid square indicates significantly lower
threshold vs that for the second seizure in the vehicle-infused group.
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Fig. 4.
Experimental FSs induce NPY gene expression in immature rat hippocampus. (A)
Hippocampal sections from naive and seizure-experiencing immature rats were subjected to
ISH for NPY mRNA (see Materials and Methods). Scale bar = 1.3 mm. (B) Quantitative
analysis of the NPY mRNA signal demonstrates increased expression in dentate gyrus
interneurons by 4 h after the seizures, and in dentate gyrus, CA3 and CA1 by 24 h. Values are
means with standard error bars. * denotes statistically significant difference compared with the
naive (control) group. Note that for neuropeptides in general, increased secretion typically
results in enhanced expression, so that the latter can be used as an indicator of endogenous
peptide release.
Dubé et al. Page 14
J Mol Neurosci. Author manuscript; available in PMC 2010 August 31.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
